HemaSphere
(Aug 2023)
P564: HOMOHARRINGTONINE AND CYTARABINE COMBINED WITH VENETOCLAX (HAV) FOR ADULT PATIENTS WITH DE NOVO AML
- Xiao-Hua Luo,
- Lin Liu,
- LI Yang,
- Yan Zhu,
- Qing Xiao,
- LI Wang,
- Xin Wang,
- Jian-Bin Chen
Affiliations
- Xiao-Hua Luo
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- Lin Liu
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- LI Yang
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- Yan Zhu
- 2 Southwest Hospital, Third Military Medical University (Army Medical University), Department of Hematology, Chongqing, China
- Qing Xiao
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- LI Wang
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- Xin Wang
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- Jian-Bin Chen
- 1 The First Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000969160.99814.64
- Journal volume & issue
-
Vol. 7
p.
e9981464
WeChat QR code